Hepatocellular carcinoma as predominant cancer subgroup accounting for sex differences in post-hepatectomy liver failure, morbidity and mortality.

[1]  D. Nagorney,et al.  Combined APRI/ALBI score to predict mortality after hepatic resection , 2021, BJS open.

[2]  S. Stättner,et al.  Sex differences in disease presentation, surgical and oncological outcome of liver resection for primary and metastatic liver tumors—A retrospective multicenter study , 2020, PloS one.

[3]  W. Dong,et al.  Effect of menopausal status on the survival and recurrence of sex-classified hepatocellular carcinoma after liver resection: a case-matched study with propensity score matching , 2020, Aging.

[4]  H. Lee,et al.  A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma , 2020, PloS one.

[5]  T. Pawlik,et al.  SRY is a Key Mediator of Sexual Dimorphism in Hepatic Ischemia/Reperfusion Injury , 2020, Annals of surgery.

[6]  J. DiStefano.  NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment. , 2020, Endocrinology.

[7]  D. Ezhilarasan.  Critical role of estrogen in the progression of chronic liver diseases. , 2020, Hepatobiliary & pancreatic diseases international : HBPD INT.

[8]  A. Mehrabi,et al.  Markers of liver regeneration—the role of growth factors and cytokines: a systematic review , 2020, BMC Surgery.

[9]  Chia-Yang Hsu,et al.  Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging Determinants , 2020, Digestive Diseases and Sciences.

[10]  Masakazu Yamamoto,et al.  Diabetes Mellitus and/or Nonalcoholic Steatohepatitis-related Hepatocellular Carcinoma Showed Favorable Surgical Outcomes After Hepatectomy , 2019, AntiCancer Research.

[11]  J. Hodson,et al.  Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study , 2019, Journal of hepatology.

[12]  H. Handa,et al.  Estradiol accelerates liver regeneration through estrogen receptor α , 2019, Clinical and experimental gastroenterology.

[13]  P. Starlinger,et al.  ASO Author Reflections: APRI + ALBI: A Novel Tool for Estimating Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastasis Undergoing Liver Resection , 2019, Annals of Surgical Oncology.

[14]  W. Lau,et al.  Sex difference in recurrence and survival after liver resection for hepatocellular carcinoma: A multicenter study , 2019, Surgery.

[15]  C. Li,et al.  Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China , 2019, JAMA surgery.

[16]  T. Gruenberger,et al.  The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy , 2019, Annals of Surgical Oncology.

[17]  K. Lassen,et al.  Contemporary practice and short-term outcomes after liver resections in a complete national cohort , 2018, Langenbeck's Archives of Surgery.

[18]  Wei Jia,et al.  Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation , 2018, Hepatoma research.

[19]  Ming‐Lung Yu,et al.  Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection , 2018, PloS one.

[20]  Wei-Chung Cheng,et al.  Estrogen receptors orchestrate cell growth and differentiation to facilitate liver regeneration , 2018, Theranostics.

[21]  N. Choijookhuu,et al.  Estrogen Accelerates Cell Proliferation through Estrogen Receptor α during Rat Liver Regeneration after Partial Hepatectomy , 2017, Acta histochemica et cytochemica.

[22]  H. Miyata,et al.  Models predicting the risks of six life-threatening morbidities and bile leakage in 14,970 hepatectomy patients registered in the National Clinical Database of Japan , 2016, Medicine.

[23]  F. Donato,et al.  Role of aetiology, diabetes, tobacco smoking and hypertension in hepatocellular carcinoma survival. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[24]  M. Schwartz,et al.  Actual 10-year survival following hepatectomy for hepatocellular carcinoma. , 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[25]  O. Farges,et al.  Incidence and Risks of Liver Resection: An All-Inclusive French Nationwide Study , 2012, Annals of surgery.

[26]  J. Parfitt,et al.  A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma. , 2012, World journal of gastroenterology.

[27]  Jürgen Weitz,et al.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). , 2011, Surgery.

[28]  P. Bachellier,et al.  Risk Factors for Liver Failure and Mortality After Hepatectomy Associated With Portal Vein Resection , 2011, Annals of surgery.

[29]  M. Nagino,et al.  Sex dimorphism in the outcome of preoperative right portal vein embolization. , 2008, Archives of surgery.

[30]  John A. Cowan,et al.  National trends in the use and outcomes of hepatic resection. , 2004, Journal of the American College of Surgeons.

[31]  N. Nagasue,et al.  Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis , 2001, The British journal of surgery.